Loading…
Suraksha Diagnostic (SURAKSHA)₹350.40+1.96%Healthcare Service Provider
Suraksha Diagnostic is compared with the 8 closest in size in Healthcare Service Provider (37 companies in the industry). It has a P/E of 50.6 against a peer median of 53.8, and ROCE of 17.0% against a peer median of 21.0%, and latest-quarter sales growth of 20.6% against a peer median of 22.2%. By market cap it is #6 of 9 in this set.
As of · Peer set: 8 closest in size in Healthcare Service Provider
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 33,877 | 62.4 | 28.0 | 22.4 | 0.08 | 0.6 | 2,755 | 510 | 19.1 | 26.9 | vs SURAKSHA |
| Vijaya Diagnostic Centre | 15,226 | 80.9 | 21.0 | 19.8 | 0.44 | 0.1 | 813 | 173 | 22.8 | 35.9 | vs SURAKSHA |
| Metropolis Healthcare | 12,055 | 59.6 | 18.0 | 13.7 | 0.15 | 0.5 | 1,646 | 190 | 16.5 | 26.6 | vs SURAKSHA |
| Thyrocare Technologies | 7,716 | 53.8 | 35.1 | 28.5 | 0.09 | 1.4 | 832 | 163 | 24.8 | −68.7 | vs SURAKSHA |
| Nephrocare Health Services | 6,238 | 147.3 | 15.0 | 8.8 | 0.07 | 0.0 | 998 | 77 | 23.7 | 33.4 | vs SURAKSHA |
| Suraksha Diagnostic | 1,826 | 50.6 | 17.0 | 14.1 | 0.53 | 0.1 | 309 | 31 | 20.6 | 44.5 | — |
| Krsnaa Diagnostics | 1,602 | 16.5 | 13.1 | 10.9 | 0.55 | 0.4 | 772 | 101 | 22.2 | −19.0 | vs SURAKSHA |
| 3B Blackbio Dx | 1,110 | 20.0 | 24.9 | 19.8 | 0.01 | 0.4 | 142 | 60 | 50.6 | −29.1 | vs SURAKSHA |
| Gaudium IVF and Women Health | 773 | 30.7 | 28.9 | 24.7 | 0.16 | 0.0 | 104 | 24 | 9.1 | −41.9 | vs SURAKSHA |
| Peer median | 6,238 | 53.8 | 21.0 | 19.8 | 0.15 | 0.4 | 813 | 101 | 22.2 | 26.6 |
Listed companies closest to Suraksha Diagnostic in Healthcare Service Provider include Dr. Lal Path Labs, Vijaya Diagnostic Centre, Metropolis Healthcare, Thyrocare Technologies, Nephrocare Health Services, Krsnaa Diagnostics, 3B Blackbio Dx, Gaudium IVF and Women Health.
Dr. Lal Path Labs, with a market cap of ₹33,877 Cr.
Suraksha Diagnostic trades at a P/E of 50.6; the median of its peer set is 53.8. A P/E above or below the median is a description, not a judgement on value.
Suraksha Diagnostic's return on capital employed is 17.0%, below the peer median of 21.0%.